Cite
HARVARD Citation
Cerchione, C. et al. (n.d.). High‐dose bendamustine plus brentuximab combination is effective and has a favourable toxicity profile in the treatment of refractory and relapsed Hodgkin lymphoma. Hematological oncology. pp. 317-318. [Online].